Isaac Chan, Pharmacology and Toxicology

Isaac Chan

Why Temerty Faculty of Medicine:
The Temerty Faculty of Medicine has made valuable scientific contributions since its founding and continues to do so by providing a well-rounded education and a wide range of resources to its students. There are ample opportunities to meet and work with world-renowned researchers who hail from different backgrounds, as well as resources that help bring innovations to the market. As an aspiring scientist with an interest in medical entrepreneurship, the Faculty is able to equip me with the knowledge and skills needed to realize my academic and career goals.

Why this Department:
The programs offered by this department give students exposure not only to the technical concepts that underlie the field of pharmacology, but also opportunities to apply these concepts through research programs and courses. Moreover, there is a considerable focus on the role of pharmacology beyond the laboratory, which allowed me to learn more about clinical and industrial applications along with the processes behind drug discovery and commercialization. 

Current Research Experience:
Currently, I am completing the PCL397Y research course (Research Abroad in Pharmacology and Toxicology) at the Karolinska Institute in Stockholm, Sweden under the Lennartsson Group. My project aims to evaluate a novel target for the treatment of acute myeloid leukemia (AML), and to characterize the efficacy of inhibitors developed by medicinal chemists at the Institute. In the coming academic year, I will be continuing my studies in AML at the Barsyte-Lovejoy Lab in the Department of Pharmacology and Toxicology through the PCL472Y Project in Pharmacology course.

Future Education Plans and/or Career Goals:
I plan to pursue graduate studies as the next step towards a career in research and, potentially, medical entrepreneurship. In the long term, I would like to be involved in the discovery of drugs against AML and the development of treatment regimens that improve the quality of life of AML patients.

Contact ambassador Isaac Chan